In contemporary clinical medicine, developmental psychopathology, and behavioral science, human variation frequently defies conventional taxonomy. Understanding what constitutes the non-normative without reflexively pathologizing biological diversity stands as one of modern healthcare’s most intricate epistemic challenges. The construct of the atypical serves as a pivotal conceptual lens through which clinicians, researchers, and diagnosticians identify presentations, trajectories, and responses that diverge significantly from expected statistical, morphological, or phenotypic norms.
Atypical
1. Concise Definition
In biomedical and psychological nomenclature, atypical designates any symptom, syndrome, developmental course, biological structure, or therapeutic response that deviates from standard diagnostic prototypes, statistical regularities, or classical clinical presentations. Rather than denoting pure pathology or complete abnormality, the term identifies non-conforming manifestations that exhibit irregular morphology, unique symptom constellations, or divergent underlying mechanisms.
Within psychopathology specifically, an atypical classification indicates that an individual meets baseline categorical criteria for a clinical entity while demonstrating defining features that invert or alter core diagnostic expectations. For instance, rather than exhibiting the classic vegetative suppression seen in melancholic states, a patient manifesting atypical affective characteristics may present with preserved emotional reactivity, hyperphagia, and hypersomnia. In somatic medicine and neurodevelopment, the descriptor flags variations ranging from divergent cellular morphology in histopathology to distinct wiring patterns across cognitive architectures.
Importantly, atypicality operates along an epistemological continuum between nominal statistical outliers and distinct qualitative pathophysiological variants. It serves as an alert system within clinical decision-making, compelling clinicians to adapt diagnostic thresholds, expand differential assessments, and tailor pharmacotherapeutic or psychosocial interventions that standard algorithmic guidelines often fail to address.
2. Etymology & Linguistic Origin
The term atypical entered the modern scientific lexicon via late nineteenth-century medical and psychological scholarship. Its morphological architecture is constructed from the classical Greek privative prefix a- (ἀ-), signifying “without,” “not,” or “lacking,” combined with the root typos (τύπος), which historically denoted a “blow,” “mark,” “impression of a seal,” “figure,” or definitive “model.” Through Latinate adaptation as typus and its post-Renaissance evolution into the French typique, Western science established “typical” as that which conforms to a discernible exemplar, template, or natural category.
By affixing the privative particle to form atypique in French and subsequently atypical in English around the mid-to-late 1880s, naturalists, neuropathologists, and alienists coined a dedicated term for phenomena that resisted classification under recognized physiological or structural templates. Early medical treatises adopted the word to characterize somatic lesions and anomalous disease courses that lacked the cardinal signs of established nosological categories. As statistical distributions and Gaussian curves colonized twentieth-century psychiatric epidemiology, the linguistic function of “atypical” expanded from describing physical malformations to demarcating non-normative psychological and behavioral manifestations.
3. Pronunciation & Grammatical Form
Pronunciation: The standard phonetic transcription in International Phonetic Alphabet (IPA) notation is /eɪˈtɪp.ɪ.kəl/ in both General American and Received Pronunciation British English, occasionally pronounced /æˈtɪp.ɪ.kəl/ in regional variations. Stress falls squarely upon the second syllable (-typ-).
Grammatical Form: Grammatically, the word functions predominantly as an adjective modifying pathological entities, clinical phenotypes, anatomical structures, or developmental trajectories (e.g., “atypical presentation,” “atypical neuroleptics,” “atypical teratoid/rhabdoid tumor”). The corresponding adverbial form is atypically, denoting the manner in which an illness unfolds or a patient responds to treatment. The abstract nominalization is atypicality (or occasionally atypicalness), which encapsulates the objective state or degree of divergence from an established benchmark or prototype.
In specialized colloquial clinical jargon, “atypical” is sometimes used as a substantive noun in plural form (“atypicals”) when referencing the class of second-generation psychotropic medications known formally as atypical antipsychotics, such as clozapine, risperidone, and olanzapine, which exhibit atypical binding affinities compared to first-generation neuroleptics.
4. Detailed Conceptual Explanation
The conceptual framework of atypicality is anchored in the tension between continuous human phenotypic variation and categorical classification systems. In biological and psychological sciences, norms are constructed either through statistical aggregation (the empirical distribution of traits across a representative population) or through teleological, normative standards (the operational integrity and functional efficacy of an organ, system, or behavior). A phenomenon is designated atypical when it falls outside standard confidence intervals or presents qualitative characteristics fundamentally divergent from recognized prototypes.
In clinical psychopathology, atypicality occupies a nuanced theoretical space distinct from simple severity. A presentation is not atypical simply because it is extremely mild or exceptionally debilitating; rather, it earns the designation because the symptom configuration violates classic expectations of the syndrome. In the context of mood disorders, for instance, atypical depression does not describe an exotic or rare condition, but rather an affective syndrome characterized by mood reactivity—where mood temporarily brightens in response to positive environmental events—alongside reverse vegetative symptoms like leaden paralysis, hypersomnia, and significant hyperphagia. This contrast highlights that atypicality reflects phenomenological and mechanistic divergence rather than epidemiological rarity.
Across neurodevelopment, the concept has undergone profound reconceptualization. Historically framed as defective or disordered maturation, non-standard cognitive, sensory, and executive configurations are increasingly analyzed through developmental systems theory. The concept of the neuroatypical or divergent trajectory recognizes that neural systems can assemble through alternative epigenetic and maturational pathways. Consequently, atypical sensory integration, communicative patterns, or social behaviors are understood as functional variations emerging from unique neuroarchitectures interacting with normative environmental constraints, shifting the explanatory focus from innate deficit to relational fit.
Furthermore, in somatic medicine and pharmacology, atypicality frequently signals divergent biological mechanisms. In clinical neurology and pulmonology, an “atypical pneumonia” is caused by non-traditional pathogens (such as Mycoplasma pneumoniae or Legionella pneumophila) that fail to produce classical lobar consolidation on radiographic imaging. In neuropsychopharmacology, atypical antipsychotics are defined by their low propensity to induce extrapyramidal motor side effects, mediated through transient dopamine D2 receptor occupancy coupled with serotonin 5-HT2A receptor antagonism. Across all domains, the construct acts as an empirical safeguard against diagnostic oversimplification, forcing practitioners to acknowledge systemic heterogeneity.
5. Historical Development
The historical trajectory of atypicality mirrors the evolution of psychiatric classification from nineteenth-century descriptive alienism to late-twentieth-century operational criteria and modern precision medicine. During the late nineteenth century, psychiatrists such as Emil Kraepelin sought to stabilize psychiatric nosology by grouping disorders based on uniform clinical courses and shared terminal outcomes. Under Kraepelin’s dual paradigm of dementia praecox and manic-depressive insanity, manifestations that failed to follow textbook developmental trajectories were cataloged as clinical curiosities or atypical variants, often relegated to the margins of scientific inquiry.
A critical shift occurred in the 1950s with the emergence of psychopharmacology. Clinicians at St. Thomas’ Hospital in London, most notably William Sargant and Eric West, observed that certain depressed outpatients who failed to respond to electroconvulsive therapy or newly discovered tricyclic antidepressants experienced dramatic clinical remissions when administered monoamine oxidase inhibitors (MAOIs). These patients presented not with classical melancholic despair, psychomotor agitation, or early morning awakening, but with intense fatigue, preserved emotional responsiveness, anxious phobic symptoms, and hyperphagia. Sargant and colleagues designated this distinct pharmacoreactive cohort as suffering from “atypical depression,” demonstrating for the first time that an atypical clinical picture corresponded directly to differential therapeutic responsiveness.
During the 1970s and 1980s, researchers at the New York State Psychiatric Institute, led by Donald Klein, Frederic Quitkin, and Michael Liebowitz, conducted rigorous double-blind, placebo-controlled trials that operationalized the diagnostic criteria for atypical affective disorders. Their findings demonstrated that specific symptom complexes—namely, mood reactivity combined with rejection sensitivity, hypersomnia, and hyperphagia—reliably predicted superior response to phenelzine over imipramine. Consequently, the American Psychiatric Association incorporated “with atypical features” as an official diagnostic specifier in the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) in 1994, cementing atypicality as an operationalized, empirically substantiated clinical construct.
Simultaneously, the late twentieth century witnessed the rise of the neurodiversity paradigm. Pioneers within sociology and autistic self-advocacy, notably Judy Singer and Jim Sinclair, co-opted the term “neuroatypical” in the late 1990s. They repurposed what had historically been a stigmatizing psychiatric label into a sociopolitical and identity-based descriptor, fundamentally challenging deficit-based models of developmental psychology and promoting recognition of neuroatypical developmental trajectories.
6. Theoretical Foundations
The conceptual coherence of atypicality relies upon three distinct theoretical frameworks: biomedical nosology, statistical developmental psychopathology, and the neurodiversity paradigm. Within biomedical nosology, atypicality is conceptualized through polythetic diagnostic systems. Unlike monothetic models that demand the presence of every cardinal symptom for a diagnosis, polythetic models accept that diseases are characterized by overlapping symptom clusters. In this context, atypical presentations represent alternative phenotypic expressions driven by shared or distinct underlying genetic risks, neurochemical imbalances, or environmental exposures.
From the perspective of developmental psychopathology, as articulated by Dante Cicchetti and Alan Sroufe, atypicality is governed by the core principles of equifinality and multifinality. Equifinality dictates that multiple divergent developmental pathways—some statistically typical, others atypical—can culminate in the same diagnostic endpoint. Conversely, multifinality posits that an identical atypical developmental starting point (such as an altered sensory threshold or atypical autonomic reactivity) can yield markedly distinct outcomes depending on environmental buffering, social scaffolding, and epigenetic triggers. Developmental atypicality is therefore not an immutable end-state, but a dynamic, transactional trajectory unfolding over time.
Finally, the neurodiversity paradigm and evolutionary psychology offer an alternative theoretical grounding. These models suggest that neurological atypicality represents balanced cognitive polymorphism maintained by frequency-dependent selection. Traits that appear atypical or non-adaptive within modern industrialized educational and occupational environments—such as intense hyper-focus, atypical sensory perception, or hyper-systemizing cognitive styles—may have conferred distinct fitness advantages within ancestral human populations. Consequently, theoretical tension persists between deficit models, which frame atypicality as structural failure, and ecological adaptation models, which conceptualize it as cognitive and biological diversification.
7. Key Components, Types & Dimensions
The construct of the atypical manifests across clinical practice through several distinct diagnostic subtypes, phenotypic dimensions, and somatic expressions:
- Atypical Affective Disorders: Characterized predominantly by Major Depressive Disorder or Bipolar Disorder with atypical features, requiring preserved mood reactivity (the capacity to experience pleasure or relief when encountering positive external stimuli) alongside at least two associated features: significant weight gain or increased appetite, hypersomnia, leaden paralysis (a profound physical sensation of heaviness in the limbs), and a long-standing pattern of interpersonal rejection sensitivity resulting in occupational or social impairment.
- Atypical Neurodevelopmental Phenotypes: Configurations of cognitive, motor, or communicative development that diverge from established milestone intervals without matching classical syndromic presentations. This includes atypical autism presentations (frequently observed in females who mask social challenges), developmental coordination atypicalities, and non-linear language acquisition trajectories.
- Atypical Psychosis: Psychotic episodes characterized by rapid shifts in emotional tone, acute confusion, dream-like states (oneirophrenia), or intense affective symptoms that do not conform neatly to the diagnostic boundaries of classical schizophrenia or bipolar mania, often exhibiting transient courses or atypical pharmacoresistance.
- Atypical Eating Disorders: Formally categorized under Other Specified Feeding or Eating Disorders (OSFED), such as atypical anorexia nervosa, wherein an individual exhibits all cognitive, behavioral, and psychological criteria of anorexia nervosa (including restrictive intake, intense fear of weight gain, and body image distortion) while maintaining a body weight at or above normal statistical parameters.
- Atypical Somatic Presentations: Medical disease manifestations wherein classical diagnostic signposts are absent, such as silent or atypical myocardial infarction presenting with epigastric distress, nausea, and diaphoresis rather than crushing substernal chest pain—a clinical pattern disproportionately observed in women, elderly patients, and individuals with diabetes.
- Atypical Pharmacological Agents: Therapeutic compounds that exert clinical efficacy through biochemical mechanisms distinct from classical drug classes, exemplified by second-generation antipsychotics displaying potent 5-HT2A antagonism relative to dopamine D2 blockade, thereby reducing motor side effects.
8. Examples & Illustrative Cases
To illuminate how the construct functions across varied clinical and diagnostic realities, consider three representative scenarios demonstrating atypicality in clinical psychology, developmental assessment, and general medicine:
Case 1: Affective Phenotype Divergence
A 28-year-old graphic designer presents for evaluation reporting persistent low mood and chronic lethargy lasting eighteen months. Unlike a patient with melancholic depression who awakens before dawn, experiences total anhedonia, and loses weight, this patient sleeps ten to twelve hours per night, craves carbohydrate-dense foods resulting in a twenty-pound weight gain, and describes their arms and legs as feeling weighed down with concrete. Crucially, when awarded a prestigious international design contract, their mood brightened dramatically for several days, demonstrating robust mood reactivity. This presentation satisfies the formal DSM-5 criteria for Major Depressive Disorder with atypical features, pointing toward potential therapeutic benefit from targeted pharmacological choices and cognitive-behavioral strategies addressing rejection sensitivity.
Case 2: Atypical Developmental Trajectory and Masking
An 11-year-old girl is referred for psychiatric evaluation due to severe school refusal, debilitating somatic complaints, and perfectionistic anxiety. Early developmental milestones for speech and motor functioning were met ahead of schedule, with advanced vocabulary acquisition. However, observational assessment and thorough developmental history reveal profound sensory hypersensitivities to fluorescent lighting and textile seams, paired with exhausting conscious imitation of neurotypical peers’ social gestures and linguistic cadence. Because her early presentation lacked overt social isolation or stereotyped motor mannerisms, her neuroatypicality remained unrecognized until rising adolescent social complexities outstripped her compensatory masking capacity.
Case 3: Somatic and Cardiopulmonary Atypicality
A 68-year-old female with long-standing type 2 diabetes presents to an emergency department complaining of sudden onset fatigue, indigestion, and jaw tension, entirely denying chest tightness or shortness of breath. Electrocardiogram and cardiac biomarker tracking reveal acute ST-segment elevation myocardial infarction. This classic atypical presentation demonstrates how neuropathic sensory alteration and biological sex differences produce divergent disease phenotypes, underscoring the lethal risks of relying solely on textbook symptom configurations.
9. Measurement & Assessment
Accurate identification of atypical presentations demands sophisticated assessment methodologies capable of discerning nuanced phenomenological variations that blunt categorical instruments typically miss.
In psychiatric diagnostics, structured clinical interviews represent the gold standard for verifying atypical features. The Structured Clinical Interview for DSM-5 (SCID-5) and the Mini-International Neuropsychiatric Interview (MINI) contain dedicated modules evaluating the precise criteria for atypical depression, systematically probing mood reactivity, rejection sensitivity thresholds, and reverse vegetative neurovegetative markers. Psychometric scales such as the Atypical Depression Diagnostic Scale (ADDS) and specialized subscales within the Hamilton Depression Rating Scale (HAM-D) and Beck Depression Inventory (BDI-II) quantify the specific severity of hyperphagia, hypersomnia, and physical lethargy.
Assessing developmental atypicality requires multidimensional, multi-informant assessment protocols. Standard cognitive evaluations using instruments like the Wechsler Intelligence Scale for Children (WISC-V) are paired with functional adaptive behavioral assessments such as the Vineland Adaptive Behavior Scales (VABS-3). Furthermore, modern assessment of atypical neurodevelopment increasingly relies on tools sensitive to subtle presentations, including the Autism Diagnostic Observation Schedule, Second Edition (ADOS-2) and the Camouflaging Autistic Traits Questionnaire (CAT-Q), which quantitatively measures the compensatory strategies individuals deploy to mask atypical social-communicative patterns.
In somatic contexts, measuring atypicality relies on functional biomarkers, continuous physiological monitoring, and advanced imaging protocols. Because atypical disease expressions systematically bypass superficial symptom screening, objective biological assays—ranging from high-sensitivity troponin monitoring in emergency rooms to continuous ambulatory polysomnography in sleep disorders—serve as essential diagnostic anchors.
10. Applications & Practical Significance
The identification of atypicality yields profound consequences across clinical medicine, educational system design, workplace accommodations, and psychiatric therapeutics. In psychopharmacology, distinguishing atypical depression from melancholia directly guides treatment selection; empirical trials indicate that patients with atypical depression typically respond poorly to tricyclic antidepressants while exhibiting heightened therapeutic responses to monoamine oxidase inhibitors, selective serotonin reuptake inhibitors (SSRIs), and bupropion.
In educational psychology, conceptualizing neurodevelopmental differences through the framework of atypicality fosters supportive neuro-affirming interventions rather than punitive behavioral modifications. By recognizing atypical sensory processing or executive functioning profiles, educational specialists design multimodal sensory environments, provide non-standard communicative channels, and implement flexible curricula that maximize learning outcomes without demanding strict behavioral conformity.
Within organizational psychology and occupational medicine, understanding atypical profiles has accelerated the development of targeted neurodiversity employment programs. Organizations increasingly recognize that cognitive atypicality—such as heightened pattern recognition, alternative lateral problem-solving, and deep analytical focus—offers critical organizational advantages when workplace environments mitigate executive strain and sensory overstimulation.
In emergency medicine and general practice, clinical vigilance regarding atypical somatic presentations saves lives. Hospital triage protocols increasingly instruct nursing and medical personnel to initiate acute cardiovascular evaluations for women and diabetic patients presenting with vague constitutional symptoms, substantially reducing mortality rates associated with missed atypical myocardial infarctions and cerebrovascular events.
11. Research & Empirical Evidence
Extensive neurobiological, genetic, and psychometric research has validated the distinct profile of atypical clinical presentations. Neuroendocrine investigations have revealed that atypical depression displays a biological signature fundamentally distinct from melancholia. Seminal research by Gold and Chrousos demonstrated that while melancholic depression is characterized by hyperactivation of the hypothalamic-pituitary-adrenal (HPA) axis, elevated circulating cortisol levels, and blunted corticotropin-releasing hormone (CRH) challenge tests, atypical depression frequently features a hypoactive HPA axis characterized by reduced baseline cortisol and heightened central sensitivity to negative feedback.
Moreover, inflammatory and metabolic research has linked atypical affective features with pronounced metabolic dysregulation. Large-scale epidemiological investigations, including the Netherlands Study of Depression and Anxiety (NESDA) led by Penninx and colleagues, found that patients with atypical depressive features exhibited significantly higher levels of circulating inflammatory biomarkers (such as interleukin-6, C-reactive factor, and tumor necrosis factor-alpha) alongside elevated rates of metabolic syndrome, obesity, and insulin resistance compared to patients with typical depressive presentations. These findings establish that atypicality often reflects distinct systemic pathophysiological processes rather than arbitrary diagnostic subtyping.
In neuroimaging and neurodevelopmental research, resting-state functional magnetic resonance imaging (fMRI) studies have demonstrated that neuroatypical profiles correlate with alternative patterns of neural functional connectivity. Rather than localized structural lesions, studies reveal distinct balances between default mode network (DMN) activity, salience network signaling, and frontoparietal central executive networks. Modern genetic architecture studies via genome-wide association studies (GWAS) further affirm that atypicality frequently represents the high end of polygenic score distributions across broad population samples, reinforcing that these traits exist along continuous biological distributions.
12. Cultural & Cross-Cultural Considerations
The boundary between what is deemed typical and atypical is heavily shaped by cultural expectations, societal values, and communicative norms. Behaviors, expressive styles, and somatic perceptions that are classified as atypical within individualistic Western psychiatric systems may represent recognized, normative adaptations within other cultural contexts.
Cross-cultural psychiatry demonstrates that the somatic manifestation of emotional distress—often labeled atypical in traditional Western nosology—is actually the global modal presentation. In many non-Western cultural contexts, including various East Asian, Mediterranean, and African societies, psychological distress is expressed through visceral bodily sensations, such as somatic distress, feeling heart-heavy, or experiencing sensations of heat, rather than purely affective statements of despair. Classifying somaticized depression as atypical reveals an Anglo-American diagnostic bias that historically privileged cognitive and affective introspection over integrated psychosomatic experience.
Similarly, social and communicative atypicality is context-dependent. Western clinical diagnostic instruments assess social engagement through sustained direct eye contact, rapid conversational turn-taking, and active self-expression. In cultures where sustained eye contact is viewed as disrespectful or confrontational, or where contemplative silence and indirect discourse are prized, normative communicative styles risk being mischaracterized as clinically atypical. Cross-cultural diagnostic competence requires clinicians to evaluate an individual’s functioning against the normative expectations of their specific sociocultural background, preventing the clinical misinterpretation of cultural divergence.
13. Criticisms, Debates & Limitations
Despite its widespread utility, the concept of atypicality generates significant debate across clinical nosology, sociology, and medical ethics. A major criticism concerns the inherent subjectivity of establishing what constitutes the “typical.” Critics argue that medical definitions of typicality frequently reflect arbitrary statistical constructs or historical conventions derived from homogeneous cohorts—predominantly young, Caucasian, male populations. When clinical models are derived from restricted demographics, non-normative expressions arising from sex-linked biological differences or socioeconomic factors are labeled atypical deviations rather than acknowledged as standard expressions across broader populations.
Nosological controversies also center on the stability and validity of categorical atypical specifiers. Psychometricians note that the DSM criteria for atypical depression exhibit high heterogeneity; two individuals can meet diagnostic thresholds for atypical affective disorder while sharing only a single symptom. Furthermore, longitudinal studies reveal diagnostic instability, with individuals frequently shifting between typical, melancholic, and atypical episodes over the course of their lives, leading advocates of dimensional models to argue that the atypical label artificially segments continuous psychiatric dimensions.
Within the disability rights community and medical humanities, the term is scrutinized for its normative bias. Sociologists argue that designating neurological or cognitive differences as atypical implicitly positions them as inferior departures from a preferred biological standard. This critique suggests that the typical/atypical binary risks preserving institutional pathologization under the guise of neutral terminology, deflecting attention away from systemic structural barriers, inadequate environmental accessibility, and institutional rigidity.
14. Related Terms & Distinctions
To preserve diagnostic accuracy, the construct of atypicality must be differentiated from adjacent psychological, psychiatric, and biological terms:
- Atypical vs. Abnormal: While “abnormal” directly denotes a state that deviates from natural function and carries an explicit implication of pathology, maladaptation, or defect, atypical indicates departure from statistical prototypes or common presentations without necessarily denoting inherent invalidity, disease, or dysfunction.
- Atypical vs. Neurodivergent: Neurodivergent is a broad, non-medical socio-political umbrella term describing any individual whose brain functions, learns, or processes information differently from the societal majority (encompassing autism, ADHD, dyslexia, and Tourette syndrome). Atypical is a clinical and descriptive descriptor applied across developmental, medical, affective, and histopathological domains.
- Atypical vs. Rare: Statistical rarity implies low epidemiological prevalence across a population, whereas an atypical presentation can be highly prevalent (for example, atypical depression constitutes an estimated 15% to 30% of clinical depressive outpatients, making it statistically common despite its non-prototypical features).
- Atypical vs. Idiosyncratic: An idiosyncratic feature refers to an entirely peculiar, individualistic, and unpredictable reaction (often pharmacological or behavioral), whereas an atypical feature follows recognized, repeatable, and clinically documented non-classical patterns.
- Atypical vs. Pathological: Pathological definitively designates an underlying diseased, damaged, or biological process. In contrast, atypical developmental patterns, cognitive variations, or personality configurations can exist as fully functional, non-pathological expressions of human biodiversity.
15. Summary / Key Takeaways
The construct of the atypical represents an indispensable diagnostic framework across clinical psychology, psychiatry, and medical practice. By identifying symptoms, illnesses, developmental pathways, and pharmacological responses that depart from classical archetypes, the concept guards against oversimplified clinical assumptions, prompts comprehensive differential assessment, and guides customized therapeutic care.
From its origins in nineteenth-century morphology to its empirical validation in psychopharmacology and its modern expansion through the neurodiversity movement, atypicality bridges the divide between categorical nosology and dimensional human variation. It encompasses distinct physiological dynamics, including hypoactive HPA axis function in depression, unique receptor affinities in pharmacology, and diverse neurocognitive architectures in human development. Ultimately, recognizing atypicality requires clinicians and researchers to balance rigorous diagnostic precision with an appreciation for biological and psychological diversity, ensuring that clinical practice adapts effectively to the reality of human variability.
References
- American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.; DSM-5-TR). American Psychiatric Publishing. https://doi.org/10.1176/appi.books.9780890425787
- Cicchetti, D., & Sroufe, L. A. (2000). The past as prologue to the future: The times, they’ve been a-changin’. Development and Psychopathology, 12(3), 255–264. https://doi.org/10.1017/s0954579400003013
- Gold, P. W., & Chrousos, G. P. (2002). Organization of the stress system and its dysregulation in melancholic and atypical depression: High vs low CRH/NE states. Molecular Psychiatry, 7(3), 254–275. https://doi.org/10.1038/sj.mp.4001032
- Penninx, B. W., Milaneschi, Y., Lamers, F., & Vogelzangs, N. (2013). Understanding the somatic consequences of depression: Biological mechanisms and the role of depression symptom profiles. BMC Medicine, 11(1), 129. https://doi.org/10.1186/1741-7015-11-129
- Quitkin, F. M., McGrath, P. J., Stewart, J. W., Harrison, W., Tricamo, E., Wager, S. G., Ocepek-Welikson, K., & Klein, D. F. (1989). Phenelzine and imipramine in atypical depression: A replication. Archives of General Psychiatry, 46(9), 787–793. https://doi.org/10.1001/archpsyc.1989.01810090029005
- Singer, J. (2016). NeuroDiversity: The birth of an idea. Judy Singer. https://www.worldcat.org/title/973541178